Filter by:
Cardiovascular
December 2024
Global CVCT Forum
Hypertrophic Cardiomyopathies – New Challenges for Future Trials
Cardiovascular
December 2024
Global CVCT Forum
EDG-7500, a First-in-Class Cardiac Sarcomere Modulator, Demonstrates Favorable Tolerability, Safety, and Pharmacokinetics in Healthy Adults and Patients with Hypertrophic Cardiomyopathy
Cardiovascular
November 2024
American Heart Association Scientific Sessions 2024
Chronic administration of EDG-7500, a novel sarcomere modulator, prevents increases in cardiac mass, T1 relaxation time, and left ventricular end diastolic pressure in a Yucatan mini-pig model of genetic non-obstructive hypertrophic cardiomyopathy
Cardiovascular
September 2024
HFSA Annual Scientific Meeting 2024
CIRRUS-HCM: An Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Effects of EDG-7500 in Adults with Hypertrophic Cardiomyopathy
Cardiovascular
September 2024
HFSA Annual Scientific Meeting 2024
EDG-7500, a First-in-Class Cardiac Sarcomere Modulator, Demonstrates Favorable Tolerability, Safety, and Pharmacokinetics in Healthy Adults
Cardiovascular
September 2024
HFSA Annual Scientific Meeting
